Related Experiment Videos
Double vessel occlusions after balloon angioplasty treated by stenting and subsequently by abciximab infusion
O F Bertrand1, D Meerkin, P de Guise
1Interventional Cardiology Laboratories, Montreal Heart Institute, Quebec, Canada. ofbert@icm.umontreal.ca
Insights
Stent thrombosis after coronary stenting can be resolved with abciximab therapy alone. This case study shows complete resolution of double vessel occlusion, leading to an uneventful patient recovery.
Area of Science:
- Cardiology
- Interventional Cardiology
- Thrombosis Research
Background:
- Stent thrombosis is a critical complication following percutaneous coronary intervention (PCI).
- Managing acute stent thrombosis remains a clinical challenge.
- Early diagnosis and effective treatment are crucial for patient outcomes.
Observation:
- A patient developed double vessel occlusion post-balloon angioplasty and stenting.
- The patient was treated exclusively with abciximab therapy.
- Control angiography was performed to assess treatment efficacy.
Findings:
- Complete resolution of thrombotic occlusions was observed on control angiography.
- Abciximab monotherapy effectively managed the stent thrombosis.
- The patient experienced an uneventful clinical course post-treatment.
Implications:
- Abciximab monotherapy may be a viable treatment option for specific cases of stent thrombosis.
- This case highlights the potential efficacy of targeted antithrombotic therapy.
- Further research into optimal antithrombotic strategies post-PCI is warranted.
Abstract:
Stent thrombosis is a serious complication after percutaneous coronary intervention. A patient is presented with a double vessel occlusion after balloon angioplasty and subsequent stenting. He was then managed by abciximab therapy alone. Control angiography showed complete resolution of the thrombotic occlusions. His subsequent clinical course was uneventful.